Ethiopia vs Mozambique: Population requiring preventive chemotherapy for schistosomiasis
Ethiopia
16.07 million
in 2024
Mozambique
18.41 million
in 2024
Ethiopia rank
5th
Mozambique rank
4th
Population requiring preventive chemotherapy for schistosomiasis over time
- Ethiopia
- Mozambique
How they compare
Mozambique currently reports 18.41 million against 16.07 million in Ethiopia, a difference of 2.34 million.
That makes Mozambique's figure about 1.1 times Ethiopia's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Ethiopia ahead.
Ethiopia ranks 5th and Mozambique ranks 4th of 52 countries.
Across the 2 decades both report, Ethiopia averaged higher in 1 and Mozambique in 1.
Head to head by decade
| Decade | Ethiopia | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 19.10 million | 13.93 million | 5.17 million | Ethiopia |
| 2020s | 15.52 million | 18.10 million | 2.58 million | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Ethiopia or Mozambique?
- Mozambique, at 18.41 million against 16.07 million in Ethiopia as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Ethiopia and Mozambique?
- 2.34 million, with Mozambique ahead.
- How many years of comparable data are there for Ethiopia and Mozambique?
- 15 years are reported by both, from 2010 to 2024.
- How do Ethiopia and Mozambique rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Ethiopia ranks 5th and Mozambique ranks 4th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.